financetom
Business
financetom
/
Business
/
Why Rocket Lab Shares Are Gaining Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Rocket Lab Shares Are Gaining Today
Jun 5, 2024 4:38 AM

Rocket Lab USA, Inc. ( RKLB ) shares are trading higher in the premarket session on Wednesday.

The company said it has concluded the second of two Electron launches for NASA’s PREFIRE climate change-focused mission, completing a turnaround of two launches within eleven days.

‘PREFIRE and Ice’ lifted from Rocket Lab Launch Complex 1, deploying the second of two satellites for the PREFIRE mission to a 525km orbit.

The company said the first mission, ‘Ready, Aim, PREFIRE,’ was successfully launched on May 25, days earlier.

“Quickly deploying both satellites to orbit within eleven days of each other demonstrates our team’s skill and experience, allowing NASA to maximize PREFIRE’s time in space collecting important climate change data,” Rocket Lab founder and CEO Peter Beck said. 

After deploying both satellites into orbit, they will traverse the Arctic and Antarctic regions to investigate the heat emitted from Earth’s polar areas.

The data gathered by the PREFIRE mission on heat loss aims to enhance climate and ice-loss models, thereby improving our ability to forecast changes in Earth’s ice, sea levels, and weather patterns. The mission is projected to continue for a duration of 10 months.

Electron has so far transported 185 satellites into space through its various launches.

Today’s mission marks Rocket Lab’s 49th Electron launch and the seventh mission of 2024.

Electron continues to hold its position as the second most frequently launched rocket in the United States each year and remains among the most frequently launched rockets worldwide, Rocket Lab said.

Information regarding Rocket Lab’s 50th Electron launch will be disclosed in the forthcoming days.

Price Action: RKLB shares are trading higher by 1.17% to $4.33 premarket at last check Wednesday.

Read Next: United Airlines Hits Brakes On Hiring This Year Due To Boeing Woes: Report

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved